Colorectal surgery
Conditions
Brief summary
Proportion of patients with any SSI within 30 days after surgery.
Detailed description
Proportion of patients with each type of SSI (superficial, deep and/or organ–space infection), Proportion of patients with surgical reintervention, Proportion of patients with anastomotic leak, Proportion of patients with postoperative complication according to the Dindo and Clavien classification, Proportion of patients with Clostridium difficile infection, Hospital readmission censored at day 30, Unexpected admission to the ICU censored at day 30, Duration of hospital stay and hospital free days, All-causes mortality, Proportion of per operative adverse events
Interventions
DRUGCHLORURE DE SODIUM 0
DRUG9 % AGUETTANT
DRUGsolution pour perfusion
DRUGCEFOXITINE PANPHARMA 1 g
DRUGpoudre pour solution injectable (IV)
Sponsors
Centre Hospitalier Universitaire De Poitiers
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with any SSI within 30 days after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients with each type of SSI (superficial, deep and/or organ–space infection), Proportion of patients with surgical reintervention, Proportion of patients with anastomotic leak, Proportion of patients with postoperative complication according to the Dindo and Clavien classification, Proportion of patients with Clostridium difficile infection, Hospital readmission censored at day 30, Unexpected admission to the ICU censored at day 30, Duration of hospital stay and hospital free days, All-causes mortality, Proportion of per operative adverse events | — |
Countries
France
Outcome results
None listed